fibromyalgia
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients will have the diagnosis of primary fibromyalgia according to the American College of Rheumatology (ACR) classification criteria. Control participants will be matched on age and educational level to fibromyalgia patients and will be healthy and pain-free as determined by a general health questionnaire, and not take any psychoactive medication or analgesics. All subjects will be adults over the age of 18 years old and speak Dutch fluently.
Exclusion criteria
Exclusion criteria: The inability to give informed consent, a serious neurological or psychiatric condition besides fibromyalgia, current participation in another research protocol that could interfere or influence the outcome measures of the present study , current use of sedative psychotropic or analgesic drugs (e.g., benzodiazepine, antiepileptics, barbiturates and opioids) except amitriptyline in low dosages (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary study parameter is the effect of attentional modulation on CPM efficacy in patients with fibromyalgia compared to healthy controls. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters are: 1) attentional task performance in patients with fibromyalgia versus healthy controls, 2) associations between CPM efficacy and cognitive inhibition, and 3) sex differences in CPM efficacy and attentional effects in fibromylagia versus healthy controls. | — |
Countries
Netherlands
Outcome results
None listed